mTOR删除通过减少CTLA4积累通过挽救自介导减轻败血症中的CD4+T细胞功能障碍
Xianli Lei1, Guoyu Zhao1, Yawen Xie1
1Department of Critical Care Medicine State Key Laboratory of Complex Severe and Rare Diseases Peking Union Medical College Hospital Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100730, China.
Mediators of inflammation
|August 6, 2024
概括
败血症会耗尽CD4+T细胞,这些细胞对免疫力至关重要. 这项研究表明,哺乳动物的拉巴素标 (mTOR) 通过控制自细胞调节CTLA4水平,提供潜在的败血症免疫疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 分子医学是分子医学.
背景情况:
- 败血症是重症监护室 (ICU) 死亡的主要原因.
- 败血症期间的CD4+T细胞枯竭显著损害了免疫功能.
- 细胞毒性T淋巴细胞相关蛋白4 (CTLA4) 负面调节T细胞激活,并通过自降解.
研究的目的:
- 调查哺乳动物目标拉巴胺素 (mTOR) 在调节败血症中CTLA4表达和积累中的作用.
- 在败血症的背景下阐明mTOR,自和CTLA4降解之间的关系.
主要方法:
- 使用了由结和穿孔 (CLP) 诱导的败血症的小鼠模型.
- 雇佣了T细胞特异性mTOR/结核性硬化综合体1 (TSC1) - 淘汰赛小鼠.
- 使用自胞体-溶解体 (A-L) 融合抑制剂bafilomycin A1,研究自胞体动态.
主要成果:
- 证明mTOR调节CTLA4的表达和积累在败血症.
- 表明mTOR调节了自的启动,特别是自-溶体 (A-L) 融合.
- 在败血症期间建立了mTOR活动和CTLA4水平之间的监管联系.
结论:
- 准mTOR是一种潜在的治疗策略,可以增强败血症患者的免疫功能.
- 根据这些发现,根据这些发现,进一步探索拉巴素在败血症中临床使用的必要性.
更多相关视频
09:10siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells
Published on: October 28, 2019
7.2K
07:30Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
10.0K
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
